fashion -WSS

fashion

author：comprehensive 2025-08-24 04:10:05 - browse：31739

President Joe Biden speaks and gestures at a podium outdoor — In addition to medical devices, the United States will raise tariffs on $18 billion worth of products including electric vehicles, batteries, and semiconductors. MANDEL NGAN/AFP via Getty Images

WASHINGTON — The Biden administration announced Tuesday that it’s raising taxes on a range of imported products from China, including syringes, needles, and surgical gloves.

Pitched as a plan to support American workers, the tariffs are meant to protect domestic manufacturers from China’s “unfair trade practices” and “artificially low-priced exports.” In addition to medical devices, the United States will raise tariffs on $18 billion worth of products including electric vehicles, batteries, and semiconductors.

Related: Drug supplies for millions would be jeopardized by U.S. crackdown on China biopharma industry, trade group says

The inclusion of syringes comes after the Food and Drug Administration’s repeated warnings to U.S. medical providers about quality issues with plastic syringes from China. The agency first alerted consumers in November 2023 about leaks and breaks associated with Chinese syringes. In March, the FDA called attention to three warning letters it sent to firms in China for selling syringes that had not received FDA clearance. It has since sent a warning letter to Cardinal Health.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Eisai exec who led development of Alzheimer’s drug to retire

hotspot

WSS

It's time to retire 'poor historian' from clinicians' vocabularies

Eisai exec who led development of Alzheimer’s drug to retire

Addiction experts warn against a second 'war on drugs'

Swim instructor mom warns parents not to buy blue swimsuits for kids

Wisconsin governor employs partial veto to fund schools for 4 centuries

Criminal prosecution for violating HIPAA: an emerging threat

Wikipedia

fashion

Related: Drug supplies for millions would be jeopardized by U.S. crackdown on China biopharma industry, trade group says

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

leisure time

Activists slam private health insurers over coverage restrictions

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

State Dept. review finds Biden bears some blame for Afghanistan failures

Parents surprise family after baby discharged from NICU after 170 days

Tori Bowie and the unacceptable rates of Black maternal death

Arc Institute generative AI designs new CRISPR systems

State Dept. review finds Biden bears some blame for Afghanistan failures

Criminal prosecution for violating HIPAA: an emerging threat

Continuity nursing helped my family in our darkest PICU moments

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

focus

Readers respond to H5N1 and livestock movements, and more

Home health providers sue Medicare over payment cuts

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

Military medical care influenced by rank and race, new study finds

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

Biden’s NIH nominee is languishing in Congress

focus

leisure time

hotspot

explore